All News

    Relief and Confidence After Biology-Guided Radiation for Breast Cancer

    August 12th 2025, 8:00pm

    Video

    A nurse with metastatic breast cancer praised biology-guided radiation for her slow-growing squamous cell cancer and the team's thoughtful care.

    Pelabresib Plus Jakafi Elicits Meaningful Responses in Myelofibrosis

    August 12th 2025, 7:00pm

    Article

    Long-term follow-up data from the phase 3 MANIFEST 2 clinical trial have been revealed.

    How Do Childhood Cancer Treatments Accelerate Biological Aging?

    August 12th 2025, 5:03pm

    Article

    Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like heart disease and obesity.

    How I Found Support While Facing a Rare Cancer Diagnosis Alone

    August 12th 2025, 4:00pm

    Article

    I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and strength to keep fighting.

    FDA Accepts NDA for Vepdegestrant in ESR1+ Advanced Breast Cancer

    August 12th 2025, 3:00pm

    Article

    The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, review date.

    Unexpected Prostate Cancer Diagnosis Changes Patient’s Mindset

    August 12th 2025, 1:00pm

    Video

    A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance of hisloved ones.

    Grounded in Words, Fueled by Purpose: Living Fully with Chronic Cancer

    August 11th 2025, 9:00pm

    Article

    Writing and reading help me stay grounded and find meaning while living with chronic cancer, balancing health, family and speaking out against hatred.

    Why It’s Important to Know That "Lung Cancer Can Affect Everybody"

    August 11th 2025, 8:00pm

    Video

    In an interview with CURE, medical oncologist Dr. Ioana Bonta explains why lung cancer is not just a ‘smoker’s disease.’

    Expanding Clinical Trial Access for Patients With Cancer

    August 11th 2025, 7:00pm

    Article

    It is vital that clinical trials for patients with cancer shift to a more representative approach to accurately reflect real-world patient populations.

    FDA Approves Companion Diagnostic Test for Hernexeos in NSCLC

    August 11th 2025, 5:14pm

    Article

    The FDA has approved the Oncomine Dx Target Test to identify patients with HER2-mutant non-small cell lung cancer who are eligible for Hernexeos treatment.